Faron’s Post

View organization page for Faron, graphic

4,493 followers

We are pleased to announce Faron has joined a research consortium that has received a United States Department of Defense (DoD) Grant to investigate the use of Traumakine®, our intravenous interferon beta-1a therapy, in preventing ischemia-reperfusion injury in battlefield victims when using a lifesaving torniquet. To read more, visit: https://lnkd.in/eKub9r7r   #Faron #Biotech #drugdevelopment

  • No alternative text description for this image
Outi Lahdenperä

Chief Project Manager at Lamus Inc.

1w

Great News ; I’m proud of your team and of all efforts for this novel therapy!

Like
Reply
Markku Saari

Product Manager at Immuno Diagnostic Oy, Microscopy and Imaging

4w

Congrats Juho and the team! That's wonderful news! Traumakine really deserves this opportunity and more 🎉🤩

Like
Reply
Petri Hollmen

Entrepreneur at Lyyti, Event Success Management professional & community founder, National Entrepreneur Award Winner 2018, Influencer of 2018 in Event Business.

1mo

💪🏻💪🏻

Like
Reply

Congratulations Juho Jalkanen MD, PhD and Faron on the DoD grant / nondilutive capital

Like
Reply
Pasi Sorvisto

Founder & Director at SPARK Finland, Director at SPARK Europe. Co-Founder of several companies.

1mo

Congrats Juho and whole Faron team!

Like
Reply
Harri Hakovirta

Professor of surgery, Turun yliopisto - University of Turku

1mo

Great news!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics